Neurotrope, Inc.
1185 Avenue of the Americas, 3rd Floor
New York, New York 10036
April 22, 2020 |
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Paul Fischer
RE: | Neurotrope, Inc. Registration Statement on Form S-3 |
File No. 333-237745
Acceleration Request
Dear Mr. Fischer:
With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of Neurotrope, Inc. (the “Company”), that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the Registration Statement to Friday, April 24, 2020, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please call Jeffrey Schultz of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (212) 692-6732 with any comments or questions regarding the Registration Statement.
Very truly yours, | ||
Neurotrope, Inc. | ||
/s/ Robert Weinstein | ||
By: Robert Weinstein | ||
Its: Chief Financial Officer |
cc: | Jeffrey Schultz, Esq.,Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |